Search Results 61-70 of 17010 for ulcerative%20colitis

  1. A Study to Evaluate Effectiveness and Safety of TD-1473 in Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis with up to 60 weeks of treatment. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  2. Inflammatory Bowel Disease (IBD) Clinical Trials - Mayo Clinic Research

    In this study, we will examine the potential side effects experienced after receiving the new hepatitis B vaccine (Heplisav-B) in patients with ulcerative ...

  3. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

    Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).

  4. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...

  5. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

    In this study, we will examine the potential side effects experienced after receiving the new hepatitis B vaccine (Heplisav-B) in patients with ulcerative ...

  6. A Study Investigating Oral Ozanimod (RPC1063) In Pediatric Participants With Moderate To Severe Active Ulcerative Colitis - Mayo Clinic

    Ozanimod will be administered orally to pediatric participants with moderate to severe active ulcerative colitis (UC) who have had an inadequate response to ...

  7. Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis - Mayo Clinic

    Confirmed diagnosis of ulcerative colitis (UC) and a history of total abdominal colectomy (TAC) with ileal pouch anal anastomosis (IPAA); Closure of ...

  8. Mesalamine dose may lower marker of bowel inflammation Videos - Mayo Clinic

    A lower level of calprotectin is associated with a lower risk of having an ulcerative colitis flare. In inflammatory bowel disease (IBD), there can be a ...

  9. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    About this study. The purpose of the trial is to determine the safety and efficacy of RPC1063 in patients diagnosed with moderate to severe ulcerative ...

  10. Hyperbaric Oxygen for Ulcerative Colitis - Clinical Trials

    Specifically, we will investigate the impact of hyperbaric oxygen therapy on clinical response/remission and serum and mucosal inflammatory markers. The ...